IM Cannabis Corp. (IMCC) is a global leader in the medical and adult-use recreational cannabis sector, operating across multiple international markets, including Germany, Israel and Canada. The company has established itself as a trailblazer in the cannabis industry, being one of the first to introduce medical cannabis to the international healthcare market. Their mission is to bring the therapeutic benefits of cannabis to patients and consumers around the world, emphasizing on improving people's lives by developing, producing, and providing both high-quality and consumer-friendly cannabis products.
IMCC's unique supply and distribution model has allowed it to stand out in the highly competitive cannabis industry. The company focuses on innovating in areas of production processes, distribution channels, and has a strong presence in the research and development sector. Its operations span cultivation, processing, product development, brand building, and direct sales to consumers.
In Israel, IMCC operates through its subsidiary, IMC, a prominent name in domestic cannabis markets with over 10 years of experience in medical cannabis. IMC is one of the leading producers and distributors of medical cannabis in Israel serving an increasing number of patients and customers under the renowned IMC brand.
The company’s business model in European Union, specifically in Germany, operates through Adjupharm, a German-based subsidiary. Adjupharm is a leader in importing, distributing, and selling pharmaceutical-grade cannabis throughout Germany, the largest regulated medical cannabis market in Europe.
In Canada, IMCC operates through Trichome JWC, a late-stage cannabis producer operating in southern Ontario. Known for producing clean, aeroponically-grown, premium cannabis products, the facility serves a rapidly growing domestic market while enabling IMCC to penetrate the international markets with Canadian grown cannabis.
IMCC prioritizes transparency and customer safety. They maintain strict quality control measures ensuring that all products are rigorously tested for potency and purity before distribution. This approach to quality, along with their innovative and customer-focused strategies, has enabled IMCC to establish a strong international reputation.
Despite having achieved substantial success, IMCC continues to strive for further growth and expansion. The company is committed to constantly innovate and improve their products to ensure they are continuously offering the best possible solutions to medical and recreational cannabis users worldwide.